Capital allocation is a matching problem. We treat it like one.
Capital Genome exists because the way businesses and institutional capital find each other has barely changed in decades, while the tools to fix it finally have.
The information exists. The intelligence does not.
Everything an investor needs to evaluate fit, and everything a founder needs to target the right capital, already exists somewhere: in filings, mandates, portfolios, project documents and track records. What is missing is a system that reads all of it, structures it and makes it usable at the moment of decision.
Modern AI makes that system possible for the first time. Capital Genome is our attempt to build it properly: with institutional standards, honest boundaries and design quality that respects the people using it.
Intelligence. Connection. Capital. In that order, because that is the order in which good outcomes actually happen.
Build it with us
Founders, investors and operators who want to shape the platform are welcome from day one.
Get in touch →